You are here: Industry Insights > COVID-19

News List

Common Medication Used to Reduce Cholesterol Levels May Reduce COVID-19 Severity firstwordpharma
July 16, 2021
In a new study from University of California San Diego School of Medicine, researchers have confirmed that patients taking statin medications had a 41 percent lower risk of in-hospital death from COVID-19.
Corvus Pharmaceuticals Discontinues Phase 3 Study of Mupadolimab (Anti-CD73) for COVID-19 Due to Vaccine Effectiveness in Reducing Hospitalizations firstwordpharma
July 16, 2021
Corvus Pharmaceuticals, Inc., today announced that it has discontinued its Phase 3 study of mupadolimab for COVID-19 due to positive trends exhibited by COVID-19 vaccines in lowering serious infection and hospitalizations.
Chilean Sinovac trial leaders recommend third dose of COVID-19 vaccine firstwordpharma
July 16, 2021
The leaders of Chile’s late-stage human trial of Sinovac’s COVID-19 vaccine CoronaVac recommended a third dose of the shot, saying studies of participants showed their protecting antibody levels were lower after six months, as reported by Yahoo!News
TrippBio receives Notice of Allowance from the U.S. Patent Office for Therapeutic Treatment of COVID-19 Infections firstwordpharma
July 16, 2021
TrippBio, today announced that the U.S. Patent and Trademark Office (USPTO) has issued a Notice of Allowance for patent application No. 16/875,487, and the European Patent Office (EPO) has issued a favorable opinion in a counterpart European application.
Almost 100% of people have antibodies after second vaccine firstwordpharma
July 16, 2021
Imperial College London and Ipsos MORI have today published their latest antibody surveillance report showing, almost 100% of people tested positive for antibodies 14 days after their second dose of the Pfizer and AstraZeneca vaccine.
NICE to develop guideline for rare blood clots associated with COVID-19 vaccination pharmatimes
July 15, 2021
The National Institute for Health and Care Excellence (NICE) will develop a guideline on the management and treatment of rare blood clots and low platelet counts associated with COVID-19 vaccination.
Two IncellDx Studies Offer a Model for Diagnosing, Monitoring and Treating Long COVID americanpharmaceuticalreview
July 15, 2021
Two new studies propose the first model for diagnosing, indexing and monitoring Post-Acute Sequelae of COVID-19 (PASC), also known as long COVID or long haul COVID.
Kintor partners with Fosun to market Covid-19 therapy in India and Africa pharmaceutical-technology
July 15, 2021
Kintor Pharmaceutical has signed a licensing agreement with Shanghai Fosun Pharmaceutical Development to market its drug, proxalutamide, for Covid-19 in India and 28 African countries.
Alcohol Tied to 740,000 Cancer Cases Worldwide in 2020 drugs
July 15, 2021
Let's not toast to this: Alcohol was linked with 740,000 new cancercases globally in 2020, representing 4% of all newly diagnosed cases that year, researchers say.
New COVID-19 Cases Doubled in U.S. in Past Three Weeks drugs
July 15, 2021
New coronavirus infections are once again climbing in the United States, driven by the highly contagious Delta variant, lingering vaccine resistance, and Fourth of July celebrations.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 437 438 Next page